Application of the Latest Immuno-Oncology Developments to the Treatment of Urothelial Cancer

Review insights from top experts in Europe and South America on new and established treatment strategies leveraging immune checkpoint inhibitors for care of patients with urothelial carcinoma with this Podcast series on-demand Webcast and downloadable slides.

Share

Program Content

Activities

ICI in UC: Spain Pearls (Spanish version)
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain in Spanish (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2021

Expires: March 10, 2022

ICI in UC: USA Pearls
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the USA (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2021

Expires: March 18, 2022

ICI in UC: Germany Pearls
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2021

Expires: May 20, 2022

ICI in UC: France Pearls
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

ICI in UC: Netherlands/UK Pearls
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2020

Expires: December 09, 2021

ICI in UC: Argentina Pearls (English Version)
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina in English (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

ICI in UC: Argentina Pearls (Spanish version)
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives from Argentina in Spanish (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

ICI in UC: Italy Pearls (English version)
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy in English (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

ICI in UC: Italy Pearls (Italian version)
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives from Italy in Italian (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

ICI in UC: Spain Pearls
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain (Podcast Pearls)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2021

Expires: March 10, 2022

Activities

Progressive UC Therapy
Current Treatment Landscape for Second and Subsequent Lines of Therapy in Metastatic Urothelial Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

First-line UC
Current Treatment Landscape in First-line Urothelial Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

Activities

Bladder Cancer IO Webcast
Application of the Latest Immuno-Oncology Developments to the Treatment of Urothelial Cancer
Congratulations: You achieved a completion on 04/09/2022

Activities

ICI in UC: United States
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2021

Expires: January 31, 2022

ICI in UC: France
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2020

Expires: November 18, 2021

ICI in UC: The Netherlands, UK
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2020

Expires: November 19, 2021

ICI in UC: Argentina
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2021

Expires: February 21, 2022

ICI in UC: Italy
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 04, 2021

Expires: February 03, 2022

ICI in UC: Spain
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 08, 2021

Expires: January 07, 2022

ICI in UC: Germany
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: May 13, 2021

Expires: May 12, 2022

Faculty

cover img faculity

Georgios Gakis, MD

Professor
Managing Staff Member
Department of Urologoy
Würzburg University
Würzburg, Germany

cover img faculity

Petros Grivas, MD, PhD

Associate Professor
Clinical Director
, Genitourinary Cancers Program
Division of Medical Oncology
Department of Medicine
University of Washington
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle Cancer Care Alliance
Seattle, Washington

cover img faculity

Marine Gross-Goupil, MD, PhD

Medical Oncologist
Department of Medical Oncology
University Hospital
Bordeaux, France

cover img faculity

Alejandro Nolazco, MD

Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina

cover img faculity

José Ignacio Nolazco, MD

Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina

cover img faculity

Thomas Powles, MBBS, MRCP, MD

Deputy Centre Lead
Centre for Experimental Cancer Medicine
Barts Cancer Institute
Queen Mary University of London
Professor of Urology Cancer
Director of Barts Cancer Centre
Department of Cancer
St Bartholomews Hospital (Barts Health NHS Trust)
London, United Kingdom

cover img faculity

Giuseppe Procopio, MD

Head of the Medical Oncology Genitourinary, Istituto Nazionale Tumori
Medical Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy

cover img faculity

Alain Ravaud, MD, PhD

Professor of Medical Oncology
Bordeaux University
Head of Medical Oncology
Department of Medical Oncology
Bordeaux University Hospital,
Bordeaux, France

cover img faculity

Óscar Rodríguez-Faba, MD

Urologist
Uro-Oncology
Fundació Puigvert
Barcelona, Catalonia, Spain

cover img faculity

Jonathan Rosenberg, MD

Attending Physician, Chief
Genitourinary Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Cora N. Sternberg, MD

cover img faculity

Michiel van der Heijden, MD, PhD

Medical Oncologist and Research Group Leader
Medical Oncology and Molecular Carcinogenesis
Stichting Het Nederlands Kanker Instituut – Antoni van Leeuwenhoek Ziekenhuis
Medical Oncologist
Antoni van Leeuwenhoek Ziekenhuis/Netherlands Cancer Institute
Amsterdam, Netherlands

Supporters

Supported by an educational grant from

Pfizer and EMD Serono